- ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!
Pfizer is making another acquisition.
The acquisition of Medivation gives the pharma giant a top-selling oncology drug and an immediate profit boost.
Pfizer buys antibiotics business from AstraZeneca; Tesla unveils Model S version that can go 300 miles on a single charge; U.S. stock futures rise slightly.
Medivation's (MDVN) stock rating was cut by several firms on Tuesday morning after the company agreed to be acquired by Pfizer (PFE) for $14 billion yesterday.